The yeast-derived Flp-frt site-speci®c DNA recombination system was used to achieve pituitary-speci®c inactivation of the retinoblastoma (Rb) tumor suppressor gene. Whereas mice carrying only frt sites in both alleles of Rb remain tumor free, tumorigenesis ensues when the Flp recombinase is expressed. The rate of tumorigenesis in these mice depends both on the expression level of the Flp recombinase and on the presence of frt sites in one or both Rb alleles. This permitted a more accurate de®nition of the consecutive steps in pituitary tumorigenesis. Our study illustrates the potential of this approach for studying sporadic cancer in a de®ned mouse model.
Introduction
Many tumor suppressor genes (TSGs) have been found mutated both in hereditary (Knudson, 1993) and sporadic forms of cancer (Brown and Solomon, 1997) . Targeted gene disruption in embryonic stem (ES) cells (Capecchi, 1989) permits the engineering of similar mutations in the mouse and makes it possible to study the eect of these mutations on growth and development in a mammalian model organism. However, homozygous loss of function mutations in mice frequently leads to complex pleiotropic phenotypes or early embryonic lethality precluding the study of their role in speci®c somatic pathologies . In addition, there might be a fundamental dierence between gene mutations transmitted through the germ line and those that are somatically acquired. While in some cases mice heterozygous for TSG mutations show a cancer predisposition resembling that of human familial cancer syndromes (e.g. Apc and p53) (Donehower, 1996; Shoemaker et al., 1997) , in other cases the disease pattern seen in man was not or poorly reproduced . The dierent physiology, genetic predisposition, lifespan and`lifestyle' between mouse and man may partly account for these dierences. In addition in mouse models for inherited cancer susceptibility syndromes, the tumor spectrum will primarily be directed to those organs in which loss of the wild type allele is rate-limiting. Consequently, the eect of TSG loss during later stages of tumorigenesis has been dicult to address.
It is reasonable to expect that mouse models will more closely mimic the human disease conditions when similar (multiple) mutations can be somatically introduced into a subset of the cells of a distinct tissue. This requires methods that enable the generation of mice composed of mutant and wild-type (wt) cells. Although chimeric mice generated by embryo fusion or injection of mutant ES cells into blastocysts partly ful®ll these requirements, they still have a number of drawbacks: (i) the variable contribution of mutant cells to the tissues, (ii) the potential deleterious eect of the mutation on processes not related to the disease of interest, (iii) unknown mutations (or epigenetic dierences) residing in the ES cell line that aect the health or modulate the disease under study, (iv) adaptive processes during early development that might modulate the eects of the mutation and, ®nally, (v) the extensive amount of labor involved as every chimeric mouse has to be generated by embryo manipulation.
Methods that permit gene inactivation in a subset of the cells in a particular tissue would overcome these problems. Tumorigenesis can then be directed to speci®c organs which enables critical parameters that aect tumor initiation and progression such as the interaction between normal and mutated cells investigated.
Tissue-speci®c gene inactivation in mice can be achieved by genetic recombination utilizing systems derived from yeast and phage P1 (O'Gorman et al., 1991; Sauer and Henderson, 1988) . These site-speci®c, DNA recombination systems are based on reciprocal recombination between unique and de®ned sequences (recombination target sites) catalyzed by a recombinase enzyme. In this setting, mice carrying recombination target sites¯anking the target gene or one or more of its exons are generated using homologous recombination in embryonic stem cells while leaving the gene functionally intact. Such conditional mutant mice are crossed with transgenic mice expressing the recombinase in a cell-type speci®c fashion. In the ospring from such crosses gene inactivation results from recombinase-mediated deletion of the gene or exon(s). The use of one of these systems, the phage P1 derived Cre-loxP system, has been extensively validated for the purpose of tissue-speci®c gene deletion in mice (Orban et al., 1992; Lakso et al., 1992; Gu et al., 1993; Kuhn et al., 1995; Tsien et al., 1996) . More recently, the yeastderived Flp-frt system has also been shown to work in mice (Dymecki, 1996) . Currently, application of these systems have not yet been described for tumor suppressor gene inactivation.
We applied this approach to achieve the cell-type speci®c inactivation of the retinoblastoma tumor suppressor gene (Rb). The Rb gene, the ®rst tumor suppressor gene identi®ed molecularly, encodes a nuclear phosphoprotein that plays a pivotal role in the decision process of a cell to enter or exit the cell cycle (for a recent review see Beijersbergen and Bernards, 1996) . In humans, inactivation of the retinoblastoma gene is associated with hereditary retinoblastoma and osteosarcoma and is also frequently found mutated in several non-familial cancers (Horowitz et al., 1990) . The importance of this cell cycle checkpoint for normal cellular control is under- (Hasty et al., 1991; Valancius and Smithies, 1991) was used to modify the Rb 1 locus with frt sites. An insertion type targeting vector was constructed containing a PGKHprt selection cassette in the opposite orientation to the Rb gene and 10.5 kb of homologous Rb regions. The frt sites (open boxes) are inserted around exon 19 into the NheI and EcoRV sites, respectively. Linearization of the targeting vector with BamHI results in a 5' and 3' homology with Rb of 2.0 kb and 8.5 kb, respectively. Homologous recombination between the targeting vector and the endogenous Rb allele results in the insertion of the complete targeting vector including the plasmid backbone (thick line) (step I). Spontaneous reversion as a result of mitotic recombination (step II) at the Rb 1 locus resulting in the removal of the inserted vector as a circularized fragment. Depending on the site of recombination the wt Rb allele (1) or the Rb frt conditional allele (2) is recovered. (b) Southern blot analysis of tail DNA of the ospring from a cross between Rb frt/+ heterozygotes after restriction endonuclease digestion with EcoRV and probing with a 3'-¯anking probe (black bar). The positions of the bands correspond to wt Rb (7 kb) allele and the frt-modi®ed Rb allele (10 kb). Wildtype animals are characterized by the presence of a single 7-kb fragment whereas a homozygous conditional Rb frt/frt genotype carries a 10-kb fragment. Heterozygous Rb frt/+ mice show both fragments. (c) Structure of the rPOMCFlp (PFlp) transgene. A synthetic intron and SV40 splicing and polyadenylation signals were used for optimal expression in mice. BamHI (B), EcoRV (R), and NheI (N) recognition sites are indicated Tissue-specific Rb inactivation M Vooijs et al lined by the fact that the majority of human cancers harbor mutations in aectors or eectors of this pathway (Weinberg, 1995) .
To study the function of the retinoblastoma gene during development as well as its contribution to cancer, the Rb gene has been disrupted in the germ line of mice (Clarke et al., 1992; Jacks et al., 1992; . Mice nullizygous for the retinoblastoma gene die at mid-gestation and show aberrant hematopoiesis and severe defects in the nervous system. Rb
heterozygotes as well as chimeric mice derived from Rb-null ES cells develop tumors of the pituitary gland (Jacks et al., 1992; Hu et al., 1994; Robanus Maandag et al., 1994; Williams et al., 1994b) . In the tumors arising in Rb heterozygotes the wt Rb allele is lost, demonstrating the critical role of Rb in preventing the development of these tumors. Chimeric mice composed of wt and Rb-de®cient cells develop normally but exhibit accelerated pituitary tumor formation (Robanus Maandag et al., 1994; Williams et al., 1994b) .
In the present work we assessed the utility of the Flp-frt site-speci®c DNA recombination system to generate conditional Rb-de®cient mice. This strategy was tested by directing Rb inactivation speci®cally to the pituitary gland, where Rb loss has been shown to be a critical event (Robanus Maandag et al., 1994; Williams et al., 1994b) .
Results

Generation of mice carrying a conditional Rb allele
An insertion type targeting vector was constructed using isogenic DNA in which two frt sequences were inserted into the introns surrounding exon 19 of Rb. Using a two step hit-and-run gene targeting strategy (Hasty et al., 1991; Valancius and Smithies, 1991) these frt sites were introduced into the mouse genome as depicted in Figure 1a . An Hprt resistance gene was included that allowed both positive and negative selection in a Hprt-de®cient ES cell line, HM-1 (Magin et al., 1992) . Excision of the region¯anked by the frt sites will result in truncation of the Rb protein. A similar mutation has been shown previously to be functionally equivalent to a null allele (Clarke et al., 1992) .
HM-1 ES cells were transfected with the linearized targeting vector and HAT-resistant colonies were analysed for homologous recombination at the Rb locus (see Materials and methods) and expanded. One clone (8-41) with a correct karyotype was reseeded at low density in the presence of 6-ThioGuanine (6TG) to select for spontaneous revertants. Resistant clones were obtained that, as a result of intrachromosomal recombination at the Rb locus, had lost the Hprt gene but retained both frt sequences (Figure 1a) . The Rb conditional allele is referred to as Rb frt . Three targeted clones were expanded, sequenced to verify the presence of the intact frt sites, karyotyped, and injected into blastocysts. All three clones gave germline transmission. Heterozygous Rb frt/+ mice were generated and crossed to obtain mice of the various genotypes (e.g. wt Rb +/+ , heterozygous Rb frt/+ and homozygous Rb frt/frt mice ( Figure 1b) . Importantly, while Rb 7/7 mutant mice are embryonic lethals,
Rb
frt/frt homozygous mice showed no signs of disease up to 14 months of age and essentially behaved as wt mice. We conclude that the frt-modi®ed Rb allele is functionally indistinguishable from the wt Rb allele.
Generation of Flp transgenic mice
To direct the inactivation of Rb to the pituitary gland we chose to use the rat pro-opiomelanocortin promoter (rPOMC). This promoter was shown to be predominantly active in melanotrophic cells of the intermediate lobe and the corticotroph cells of the anterior lobe of the pituitary gland of transgenic mice (Hammer et al., 1990) . rPOMC SV40 large T-antigen transgenic mice develop intermediate lobe tumors similar to those in Rb heterozygotes (Low et al., 1993) . In addition, the pituitary adenomas that arise in Rb heterozygotes express POMC mRNA (Harrison et al., 1995) and amelanocyte stimulating hormone (a-MSH), a processed product of the POMC precursor protein (Hu et al., 1994; Robanus Maandag et al., 1994; Williams et al., 1994b) .
A 770-bp fragment of the rPOMC promoter was used to drive an optimized version of the Flp gene (Buchholz et al., 1996) with a synthetic intron at the 5' end and a SV40 polyadenylation signal and intron at the 3' end ( Figure 1c) . A total of ®ve independent transgenic lines were produced by pronuclear injection of the rPOMC-Flp (PFlp) DNA construct. The copy number of the transgene in these lines ranged from 5 ± 16. One transgenic line PFlp1, carried two independent integrations 1a and 1b, that segregated in subsequent generations. One of these (1b), was integrated in the Y chromosome and, consequently, only transmitted from male to male. All the PFlp transgenic mice were healthy and fertile and showed no signs of disease. We crossed the PFlp1 founder with heterozygous Rb frt/+ mice to obtain PFlp;Rb frt/+ mice. These mice were subsequently bred to Rb frt/frt mice to obtain PFlp;Rb frt/+ and PFlp;Rb frt/frt mice. These crosses resulted in the segregation of PFlp1a. and PFlp1b. transgenes to the various Rb frt genotypes.
Pituitary gland tumors
Histological analysis of control Rb frt/+ and Rb frt/frt pituitary glands from 10 ± 12 weeks of age revealed no histological abnormalities (Figure 2a, b) . In contrast, PFlp1a;Rb frt/+ mice at 6 and 12 weeks of age showed atypical lesions in the intermediate lobe of the pituitary gland that could be easily distinguished from the normal cytological appearance of the surrounding melanotrophs (Figure 2c,d ). These lesions, predominantly located at the neuro-intermediate border, were comprised of cells with large irregular shaped nuclei, with a high nuclear/cytoplasmic ratio a dense network of chromatin and pleiomorphic in shape. Tumors in PFlp1a;Rb frt/+ mice arose as a consequence of Flpmediated inactivation of the Rb frt allele and subsequent loss of the wt allele. Since loss of the wt allele is ratelimiting for the development of these tumors, we expected that Flp-mediated inactivation of both alleles in PFlp1a;Rb frt/frt mice would result in an accelerated tumor development. Indeed, PFlp1a;Rb frt/frt littermates at 12 weeks have large tumors to which they succumb within 20 weeks of age (Figure 2e,f) . By morphological Maandag et al., 1994; Williams et al., 1994b; Nikitin and Lee, 1996) . Immunostaining, using an antibody that recognizes a-MSH was used to demonstrate the melanotrophic characteristics of these tumors (not shown).
A small cohort of PFlp1a;Rb frt/+ (n=11), PFlp1a;Rb frt/frt (n=10) , PFlp1b;Rb frt/frt (n=14) mice was monitored for tumors ( Figure 2g ). Rb frt/ko (n=18) mice were used as a reference for the onset of spontaneous Flp-independent tumors. Mice were (Figure 3a) . PCR ampli®cation and sequencing of tumor DNA showed that these were the result of precise Flp-mediated recombination (not shown). PCR analysis on tissue DNA isolated from a tumor bearing mouse (Figure 3b) showed that Flp-mediated inactivation of Rb in this transgenic mouse was restricted to the pituitary gland, in agreement with the tissue-speci®city of the rPOMC promoter (Hammer et al., 1990) . Mixing of normal and tumor DNA in dierent ratios showed that the detection limit for recombination under these circumstances was between 1 ± 5%. Therefore, we cannot exclude that in some tissues recombination had occurred at a lower level as a result of ectopic Flp expression.
To address the question whether spontaneous, Flpindependent, recombination occurred at the frt sites in the Rb locus, we crossed Rb frt and Rb +/7 (Clarke et al., 1992) mice to generate Rb frt/ko mice. Analysis of several independent tumors that arose spontaneously in these mice revealed that these tumors were the result of complete loss of the frt-modi®ed Rb allele rather than a consequence of Flp-independent frt recombination ( Figure 3a) . We conclude that Flpindependent recombination is below the rate of spontaneous chromosome loss or deletion events at the Rb locus in this tissue (Hu et al., 1994; Nikitin and Lee, 1996) .
Transgene dependent onset of tumors
One strain, PFlp1b, which transmitted the transgene only to male ospring, showed a reduced capacity to induce tumors in the Rb frt background. Whereas the PFlp1a;Rb frt/frt strain succumb to tumors within 20 weeks, PFlp1b;Rb frt/frt mice died of tumors within a time frame of 11 months (Figure 2g ). Histological analysis of PFlp1b;Rb frt/+ mice at 12 weeks of age infrequently showed the appearance of hyperplastic areas (not shown). In contrast, PFlp1b;Rb frt/frt analysed at 6 weeks and at 12 weeks (Figure 4 ) of age showed extensive hyperplasia containing areas with more densely packed cells with a nodular appearance, resulting in a general increase in intermediate lobe cell mass at 12 weeks. The cell density of these hyperplastic areas and nodules was on average 2.5-fold higher than the cell density of normal intermediate lobes in Rb frt/frt control mice (not shown). As in end-stage tumors, the majority of cells in the hyperplastic tissue stained positive for a-MSH albeit less homogenously than control pituitaries (not shown).
Rb loss is associated with the earliest detectable cytological abnormalities To investigate whether hyperplasia was a cell autonomous feature of Rb de®cient cells we used a semiquantitative PCR-microdissection technique to determine the Rb status in the morphologically distinct hyperplastic and nodular areas within the intermediate (lanes 9 ± 12). The 5.0-kb fragment corresponds to the Rb frt allele, the 4.5-kb band to the deleted Rb D19 allele and the 4.2-kb fragment to the Rb ko allele (Clarke et al., 1992) . Spontaneous tumors in Rb frt/ko mice arise through a loss or partial deletion of the Rb frt allele, while tumors in PFlp;Rb frt mice arise as a consequence of Flp-mediated excision of exon 19. Under these conditions wt and frt-modi®ed Rb alleles (lanes 1 ± 4) are not well resolved during electrophoresis therefore the genotype was determined by PCR (see Materials and methods). (Figure 5a,b) . Analysis of PCR products derived from hyperplastic (H) and nodular (N) lesions revealed that in specimens from the hyperplastic regions the intensity of the fragment diagnostic for the recombined allele was signi®cantly higher than the fragment characteristic for the Figure 3b ). Note that in some areas complete Rb loss is found without any obvious histological abnormalities (see text). Bar=120 mm (a,b) unrecombined frt-allele whereas in the nodular regions the frt-allele was hardly detectable (Figure 5) . Since under the experimental PCR conditions used there was a preference for the ampli®cation of the unrecombined frt-allele, this indicates that the vast majority of the cells present in the hyperplastic area and virtually all cells in the nodular regions have undergone recombination on both alleles, and as a consequence, have become Rb-de®cient.
Early loss-of Rb does not aect normal pituitary gland development During normal development of the pituitary, proliferation of melanotrophs decreases after post natal day 1 (PND) and ceases almost completely between PND 35 and 60 (Nikitin and Lee, 1996) . To examine the consequence of early Rb inactivation on pituitary gland development we compared the frequency of Rb inactivation with the histological appearance of pituitary glands at PND 7, a stage when melanotroph cells still proliferate. Histological analysis of pituitary glands from one-week-old PFlp1a;Rb frt/+ and PFlp1a;Rb frt/frt littermates revealed no marked difference in histological appearance (not shown). PCR microdissection was used to investigate the extent of Rb loss at several areas within the intermediate lobe. In PFlp1a;Rb frt/frt pituitaries, the frequency of Rb inactivation varied between 30 ± 100% while in heterozygous PFlp1a;Rb frt/+ littermates complete loss of the frt allele of Rb was found in some sampled areas with no evidence for loss of the wt allele (Figure 5d ). Apparently the presence of a signi®cant fraction of Rb-de®cient cells does not aect pituitary gland development at this early stage.
Rb loss results in hyperproliferation
We expected that if the earliest detectable cytological abnormalities already are composed of a signi®cant number of Rb-de®cient cells then this might result in increased proliferation in these areas consistent with the role of Rb as a negative regulator of the G1-S transition. To investigate whether the appearance of atypical cells in these mice was associated with an increase in cell proliferation, mice were injected with BrdU and sacri®ced 2 h later. Histological examination and staining for BrdU showed that proliferating cells were predominantly located in the nodules of PFlp1a;Rb frt/+ and PFlp1b;Rb frt/frt mice (Figure 6a,b) . In tumors from PFlp1a;Rb frt/frt littermates of the same age BrdU labeling was abundant and scattered throughout the tumor tissue (Figure 6c ). To permit a better assessment of the proliferation status of pre-neoplastic stages and tumors we investigated the expression of Ki-67, a nuclear protein expressed throughout the cell cycle of cycling cells (Schluter et al., 1993) . While control Rb frt/frt mice did not show any staining, abundant nuclear staining was observed in both hyperplastic areas and nodular areas within specimens from PFlp1b;Rb frt/frt mice at 10 weeks of age and in tumors from PFlp1a;Rb frt/frt mice (Figure 6d ± f) . 
Reduction of apoptosis during tumor progression
Histological analysis of hyperplastic lobes showed melanotrophic cells with fragmented nuclei and condensed chromatin that were typical for ongoing programmed cell death (apoptosis). Terminal deoxynucleotidetransferase mediated deoxyuridine nick-end labeling (TUNEL) con®rmed that these aberrant cells underwent apoptosis (Figure 6g ± i) . Apoptotic cells were primarily observed in the hyperplastic intermediate lobe of PFlp1a.;Rb frt/frt mice of 4 ± 6 weeks while virtually absent in end-stage tumors from 10 ± 12 week old PFlp1a.;Rb frt/frt mice as well as in the intermediate lobe of control mice. These results suggest that impairment of apoptosis may be one of the mechanisms involved in the progression of Rb-de®cient hyperplastic melanotrophs to tumors.
Discussion
Our data indicate that the Flp-frt site speci®c recombination system can be eectively used to inactivate conditional mutant tumor suppressor gene alleles in a de®ned cell type in mice. This allows analysis of the tissue-speci®c and temporal requirements for gene function during development and in the adult animal without the complications associated with germ line gene-inactivation. Of particular interest is the use of these systems to generate mouse models for somatically acquired diseases such as cancer. Here we report pituitary-speci®c disruption of the Rb gene. Rb conditional mutant mice behave as normal mice and only upon breeding with transgenic mice expressing the recombinase, gene-inactivation will ensue in the ospring in the tissues expressing the recombinase. Three factors are critical in this approach: (i) The target recombination sites should not interfere with the normal functionality of the gene, e.g. interfere with transcription or splicing when placed within introns as is the case in the Rb conditional allele described here; (ii) No spontaneous recombination should occur in the absence of the recombinase; and (iii) Expression of the recombinase should lead to a considerable level of excision of the fragment¯anked by recombination sites. The Flp-frt recombination system appears to ful®ll all these criteria.
Our decision to conditionally delete exon 19 was based upon our earlier experience in which the Rb gene was disrupted by insertion of a selectable marker in exon 19. This resulted in an allele that was functionally null (Clarke et al., 1992) . We used a fragment of the rPOMC promoter shown to be speci®c for the corticotrophs of the anterior lobe and the melanotroph cells of the intermediate lobe of the pituitary gland in transgenic mice (Hammer et al., 1990) to drive expression of the Flp recombinase. We have investigated the tissue-speci®city of the rPOMC promoter in mice by crossing rPOMC-Cre transgenic mice with a reporter mouse strain that allows the in situ identification of cells that as a result of recombination switched on a silent LacZ gene (Akagi et al., 1997) and found that expression is restricted to the intermediate-and anterior lobe of the pituitary gland. PCR analysis indicated no recombination in tissues other than the pituitary gland. PFlp transgenic mice are healthy and fertile as was found for mice with ubiquitous expression of Flp (Dymecki, 1996) .
Disruption of Rb in the pituitary gland leads to tumors
Rb heterozygous mice are predisposed to tumors of the pituitary gland with a 100% incidence (Hu et al., 1994; Robanus Maandag et al., 1994) . Since Rb inactivation is a rate-limiting step in the development of this tumor in mice (Robanus Maandag et al., 1994) somatic pituitary-speci®c inactivation of Rb should lead to tumors. Indeed, crossbreeding of Rb conditional mutant mice with several independent PFlp transgenic mice resulted in pituitary tumors in all PFlp;Rb-frt ospring. In PFlp;Rb frt/+ mice these tumors were the result of Flp-mediated deletion of the frt-modi®ed Rb allele and subsequent loss of the remaining wt allele, a situation mimicking the stochastic nature of mutations in human sporadic cancer. In two independent PFlp strains, the presence of frt sites on both Rb alleles resulted in an accelerated tumor development. This indicates that Flp recombination may occur eciently on multiple alleles within one cell and further substantiates the importance of the loss of Rb as rate limiting step in pituitary tumorigenesis. Tumors arose from the melanotrophic cells in the intermediate lobe as based upon morphological and immunocytochemical criteria. No other abnormalities were found in these mice consistent with the ®nding that recombination was not detected in tissues other than the pituitary gland.
Rb loss is required but not sucient for the development of melanotroph tumors Histological analysis of early stages of tumorigenesis revealed areas within the intermediate lobe that had distinct histological features (e.g. normal vs hyperplastic vs nodular). Examination of the Rb-status in these distinct lesions showed signi®cant Rb loss associated with the earliest detectable cytological abnormalities and complete Rb loss in nodular type areas and endstage tumors. These results corroborate earlier studies that Rb inactivation is an initiating event in melanotroph carcinogenesis in mice (Nikitin and Lee, 1996) .
In accordance with these observations we found Rb loss to result in inappropriate entry into S-phase as con®rmed by the large number of cells positive for BrdU incorporation and Ki-67 labeling throughout the hyperplastic lobe and the dispersed nodules. While the extent of proliferation between the nodules in early stages of the disease and the tumors from mice with end-stage disease was comparable we found a marked reduction of apoptosis in the latter. These observations suggest that mutations that impair apoptosis of Rbde®cient melanotrophs is one of the events that is required for tumor progression in this mouse model.
Our data do not permit a de®nition of the exact stage at which these alterations occur during tumor progression. The fact that both hyperplastic areas and nodules are predominantly composed of Rb-de®cient cells but show such a distinct histological appearance may be explained both by cell autonomous and noncell autonomous mechanisms; (i) the transition from hyperplasia to nodule may represent a clonal outgrowth of a hyperplastic cell that has acquired secondary genetic alterations or; (ii) hyperplastic areas and nodules show dierent growth characteristics due to a dierence of microenvironment that may be determined by the fraction of wt cells present in the area or (iii) nodules may result form early Rb inactivation leading to clonal outgrowth while hyperplastic area's resulted from Rb loss at a later timepoint.
In several mouse models apoptosis associated with Rb loss has been shown to be both p53-dependent and -independent (Morgenbesser et al., 1994; Symonds et al., 1994; Macleod et al., 1996) . In Rb +/7 ;p53 +/7 mice pituitary tumorigenesis was accelerated but no loss of the wt p53 allele was found in these tumors (Williams et al., 1994a; Harvey et al., 1995) suggesting that p53 is not involved although a small synergistic eect due to haplo-insuciency of the p53 allele cannot be excluded (Donehower, 1996) . Our results indicate that mutations in the apoptotic pathway are likely responsible for the progression of pituitary adenomas from Rb-de®cient melanotrophic cells. Involvement of Bcl-X L has been reported as a tumor progression step in the development of insulinomas in RIPTag transgenic mice (Naik et al., 1996) , and crosses between Bax-de®cient mice and SV40Tag transgenic mice resulted in an accelerated development of brain tumors (Yin et al., 1997) . These aspects will be addressed in genetic crosses between tissue-speci®c Rb knock-outs with mice carrying mutations that aect these apoptotic pathways.
The Flp recombination system
So far most experience has been gathered with the CreloxP system for inactivating genes in mice, which has been reported to enable almost 100% gene-deletion in some cases. Such a high recombination eciency may be essential for certain applications of this technology such as in the study of learning and memory (Tsien et al., 1996) or T-cell development (Gu et al., 1994) . It seems that the expression characteristics of the recombinase plays a critical role in determining the eciency of gene deletion. Two factors are important in this respect. The level of expression of the recombinase in a particular cell, and the uniformity of expression in a particular cell type. Stochastic high expression of the recombinase in some cells of a particular tissue might give the impression of a poor recombination eciency, even though multiple alleles may have been switched in the cells in which the recombinase was expressed. These two features cannot be distinguished when analyses are performed on total tissue extracts. In situ detection using suitable reporter mice is therefore required. For the study of sporadic cancer the frequently observed stochastic expression of transgenes (Donoghue et al., 1991; Robertson et al., 1995; Festenstein et al., 1996; Betz et al., 1996) is fortuitous as it will permit switching of multiple alleles in a fraction of the cells, thereby mimicking the situation encountered in normal tumorigenesis in which mutant cells are surrounded by wt cells that convey growth inhibitory signals.
The Flp system has been shown to work eciently in Drosophila (Golic and Lindquist, 1989) , but it has been reported to be less ecient in mammalian cells (O'Gorman et al., 1991; Jung et al., 1993; Fiering et al., 1993; Dymecki, 1996) possibly due to the thermolability of Flp protein (Buchholz et al., 1996) . Our data show that Flp-mediated recombination using a modi®ed Flp transgene (Buchholz et al., 1996) permits ecient recombination that can approach 100%. Furthermore, by selecting dierent transgenic strains the frequency of gene excision can be modulated as is observed for Cre-mediated recombination.
The utility of these conditional mutant mice may be further increased by using interferon, tamoxifenor tetracyline inducible gene expression systems that enable controlled recombinase expression (Kuhn et al., 1995; Kistner et al., 1996; Feil et al., 1996) or through the use of replication-de®cient adenoviruses (Wang et al., 1996; Akagi et al., 1997) which enable spatial and temporal control over genedeletion.
Taken together our results illustrate the utility of site-speci®c DNA recombination systems for studying the role of tumor suppressor genes in sporadic cancer. An obvious extension will be to combine multiple conditional mutations, permitting the tissuespeci®c introduction of a de®ned set of mutations, e.g. as found in particular human cancers. This will enable a better understanding of the role of the individual genes involved in the onset and progression of the disease and will likely also provide us with better models to test therapeutic intervention protocols.
Materials and methods
Construction of an Rb conditional allele
A mouse 129/Ola mouse genomic library was screened and a 17-kb Rb genomic clone was isolated as described previously (te . A 10.5-kb SalI ± BamHI fragment was used for the construction of the Rb frt targeting vector. A 50 bp oligonucleotide containing the 48-bp frt site (uppercase) 5'-atGAAGTTCCTATTCC-GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC-3' (O'Gorman et al., 1991) and the complementary oligo were annealed and blunt-end cloned in the same orientation into NheI and EcoRV sites respectively in the introns anking exon 19 of Rb, encompassing 400 bp of Rb sequence. Flp mediated excision of exon 19 results in a frameshift leading to the removal of 300 amino acids from the carboxy-terminus. A 2.8 kb EcoRI ± BglII fragment containing the PGKHprt mini-gene (van der Lugt et al., 1991) was inserted between EcoRI and BamHI sites in reverse orientation to the Rb gene. The Rb frt targeting vector was linearized at a unique BamHI site resulting in 2 kb of 5' homology and 8.5 kb of 3' homology and electroporated into the isogenic (HM-1) Hprt-de®cient 129/ Ola ES cell line (Magin et al., 1992) using conditions described (Clarke et al., 1992) . ES cells were selected on HAT medium (100 mM Hypoxanthine, 0.8 mM Aminopterin, 20 mM Thymidine, Gibco) for 10 days. Homologous recombinants were analysed using an EcoRI/NheI doubledigest and an external probe located at the 5' end (te resulting in a band of 10 kb for the targeted allele and a 5-kb fragment for the wt Rb allele (not shown). One of these was karyotyped, and reseeded at low-density (4610 5 cells/100 mM dish) on gelatin coated dishes in BRLconditioned medium containing 10 mg/ml 6-ThioGuanine (6TG, Sigma) for 9 days. 6-TG resistant clones were recovered at a frequency of 3610 76 . About 16% (11 out of 68) of these had undergone the correct recombination event and contained both frt sites (not shown). Three of these were sequenced, karyotyped, and injected into recipient C57Bl/6 blastocysts and transferred to (C57Bl/6 x DBA) pseudopregnant mothers. Germline transmission was obtained from all three clones after mating of male chimeric mice (129/Ola:C57Bl/6) with FVB/N (Taketo et al., 1991) females. Heterozygous Rb frt/+ mice derived from one clone (frt-17) were used for all subsequent experiments.
Generation of transgenic mice A 1.7-kb XbaI ± XhoI fragment derived from pOG44-®x (a gift from Stephen O' Gorman , The Salk Institute, CA) containing a modi®ed version of the Flp gene (Buchholz et al., 1996) and a synthetic intron was blunt-end cloned into the EcoRI site of a cassette containing 770 bp of the rat proopiomelanocortin promoter (rPOMC) (Hammer et al., 1990) , and 840 bp of SV40 small t-antigen intron and polyadenylation signals at the 3' end (A gift by Malcom Low, Vollum Institute, Oregon). The 3.3 kb ApaI ± BamHI rPOMCFlp transgene was isolated, puri®ed and injected at 3 ng/ml into zygotes from superovulated FVB/N mice (Taketo et al., 1991) .
Genotyping of mice
The genotypes of all ospring were analysed by southern blotting or polymerase chain reaction (PCR) on tail-tip DNA . For Southern blot analysis, tail DNA (8 mg) was digested with EcoRV, separated in 0.8% agarose gel by electrophoresis, transferred to nylon membranes (Schleicher and Schuell) and hybridized with 32 P-Klenow labeled probes according to manufacturers' conditions. A 260-bp ClaI ± HindIII fragment was used as a hybridization probe to detect wt and frt alleles and a 1.4-kb BamHI fragment containing the Flp gene was used to detect the rPOMCFlp transgene. For genotyping of tail-tip DNA by PCR, genomic DNA was ampli®ed with primers Rb19 (5'-AACTCAAGGGAGACCTG-3') and Rb18 (3'-GTAACTACCGTGTGCGG-5') yielding a 680-bp product for wt allele and a 780-bp product for the frt-modi®ed Rb allele. Thermocycling conditions consisted of 30 cycles of 30 s at 948C, 30 s at 588C and 50 s at 728C. Reactions contained 200 ng template DNA, 0.5 mM primer, 100 mM dNTP's, 9% glycerol, 2.5 u Taq polymerase, 1.8 mM MgCl 2 , 16 PCR buer (Gibco-BRL) in a 20 ml volume. For the isolation and analysis of tumor and tissue DNA the same procedures were used as for tail DNA except that the tumor DNA was digested with PstI and Southern blots were hybridized with a 450 bp PstI ± PvuII probe comprising exon 18 of Rb (Clarke et al.,1992 
Histological analysis of tissues
Pituitaries were isolated under a dissection microscope and ®xed in 4% neutral buered formalin embedded in paran, sectioned at 6 mM thickness and stained with Haematoxylin and Eosin (H-E) according to standard procedures. Cell densities were determined under 64-fold magni®cation from 20 independent hyperplastic and nodular areas from the same specimen and 20 independent areas from control mice. Statistical analysis was performed on 20 independent ®elds from hyperplastic and nodular areas recorded in a specimen (Wilcoxon-test). Photomicrographs were collected and arranged in Adobe Photoshop.
In situ detection of proliferation and apoptosis
For in situ proliferation analysis mice were injected intraperitonally with a dose of 100 mg/g bodyweight of BrdU (Sigma) in 0.9% saline and sacri®ced 2 h postinjection. For the detection of BrdU incorporation and the labeling of apoptotic cells by the TUNEL method, paran embedded sections (6 mm) were deparanized and washed in PBS. BrdU incorporation was detected after antigen retrieval, with an alkaline phosphatase conjugated antiBrdU antibody and visualized using Fast Red as a substrate (Boehringer Mannheim). For the detection of apoptosis by TUNEL, sections were pretreated with proteinase K (2 mg/ml in 10 mM Tris-HCl pH 7.4) for 15 min at 258C and further treated according to manufactures' conditions (Boehringer Mannheim). Sections stained with alkaline phosphatase were counterstained with haematoxylin and mounted in an aqueous based medium.
Indirect immunohistochemistry and antibodies
Rabbit antisera against a-MSH (1 : 500, SeraLab) were incubated for 2 h at 228C in blocking buer (10% normal goat serum, 0.4% Triton x-100 in PBS) and subsequently detected with the ABC system (Vector) and Diaminobenzidine (0.05% DAB, 0.03% H 2 O 2 in 50 mM Tris-buer (pH 7.4)) as substrate. For the detection of Ki-67 the MIB5 monoclonal antibody (1 : 50, Immunotech) was used incubated for 2 h at 228C and detected using the Vectastain kit (Vector) and DAB as substrate. Immunostaining for Ki-67 required antigen retrieval in 10 mM Citrate-buer (pH 6). Omission of primary antibodies was always included as a negative control. Sections were counterstained with haematoxylin for 10 s and mounted.
PCR microdissection
Microdissection, DNA isolation and PCR ampli®cation were essentially performed according to Nikitin and Lee (1996) . Brie¯y, H-E stained sections were photographed unmounted in xylene, rehydrated to H 2 O and air-dried. Sections were covered with 20 ml of TE overlaid with paran oil and viewed under an olympus inversion microscope equipped with Nomarski optics. Approximately 30 ± 80 cells were dissected under 300-fold magni®cation using glass needles and transferred to 20 ml of proteinase K lysis buer incubated for 1 h at 568C after which the proteinase K was inactivated for 10 min at 968C. Half of this, 10 ml, was used for subsequent PCR ampli®cation using primers Rb-212 (5'-GAAAG-GAAAGTCAGGGACATTGGG-3'), Rb-18 (3'-GTAAC-TACCGTGTGCGG-5') and Rb-19E (5'-CTCAAGA-GCTCAGACTCATGG-3') yielding a 283-bp product for the unrecombined Rb frt allele a 260-bp product for the recombined Rb D19 allele and a 235-bp fragment for the wt Rb allele. Primers Rb-212 and Rb-18¯ank the deleted region while primer Rb-19E, located within the deleted region, together with Rb-18 is used to detect the unrecombined Rb allele. PCR cycling consisted of an initial denaturation of 3 min at 948C followed by 40 cycles of 30 s at 948C, 50 s at 588C and 50 s at 728C. PCR reactions consisted of 0.4 mM primer, 200 mM dNTP's, 9% glycerol, 2.5 u Taq polymerase, 16 PCR buer (Gibco-BRL) in 50 ml. A hot-start protocol was followed using HOT-WAX MgCl 2 beads (1.5 mM, Invitrogen). For the detection of recombination in tissue extracts from PFlp1a;Rb frt/+ mice the same protocol was followed except that template DNA was 40 ng and ampli®cation was for 35 cycles. Control ampli®cations were always included and consisted of a mixture of PFlp;Rb frt tumor-derived and control Rb frt/frt DNA (100 pg each) in a 1 : 1 ratio diluted in
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